Ongoing clinical trials in AKI
S Faubel, LS Chawla, GM Chertow… - Clinical Journal of the …, 2012 - journals.lww.com
AKI is an important public health issue. AKI is a common hospital complication associated
with increased in-hospital and long-term mortality, extensive morbidity (including prolonged
hospital length of stay), and an estimated annual cost of at least $10 billion in the United
States. At present, no specific therapy has been developed to prevent AKI, hasten recovery
of kidney function, or abrogate the deleterious systemic effects of AKI. However, recent
progress includes establishing a consensus definition of AKI and discovery of novel …
with increased in-hospital and long-term mortality, extensive morbidity (including prolonged
hospital length of stay), and an estimated annual cost of at least $10 billion in the United
States. At present, no specific therapy has been developed to prevent AKI, hasten recovery
of kidney function, or abrogate the deleterious systemic effects of AKI. However, recent
progress includes establishing a consensus definition of AKI and discovery of novel …
